2Sandhu JS. Renal effects of selective cyclooxygenase( COX -2 )inhibitiors. J Indian Acad Clin Med,2003,4( 1 ) :18 -20.
3Jean-Pierre Guignard, The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit Seminars in Perinatology, 2002,6(26) : 398 -405.
4Segal R,Lubart E, et al. Renal effects of low dose aspirin in elderly patients. Isr Med Assoc J. 2006,8 (10) :679 - 82.
5Whelton A. Renal and related cardiovascular effects of conventional and cox-2-specific NSAIDs and non-NSAID analgesics. Am J Ther, 2000,7:63 -74.
6Meune C, Mahe I, Mourad JJ,et al. Interaction between angiotensin- converting enzyme inhibitors and aspirin: a review. Eur J Clin Pharmacol,2000,56 ( 9 - 10 ) :609 - 620.
7Guazzi MD, Campodonico J. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther, 1998,63 ( 1 ) :79 - 86.
8Ahmed A. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? J Am Geriatr Soc,2002,50 (7) :1293 - 1296.
9Loboz KK, Shenfield GM Drug combinations and impaired renal function -the triple whammy: Br J Clin Pharmacol,2005,59 (2): 239 - 43.
10Andre P, Nannizzi-Alaimo L. Platelet-derived CD40 L: the switch-hitting player of cardiovascular disease. Circulation,2002,106 : 896-899.
